Role of hydrogen sulfide in subarachnoid hemorrhage. (22nd March 2022)

• Record Type: Journal Article
• Authors: Lu, Dengfeng; Wang, Lingling; Liu, Guangjie; Wang, Shixin; Wang, Yi; Wu, Yu; Wang, Jing; Sun, Xiaoou
• Is Part Of: CNS neuroscience & therapeutics. Volume 28:Number 6(2022)
• Page Start: 805
• Page End: 817
• Publication Date: 2022-03-22
• Subjects: apoptosis -- cerebral edema -- hydrogen sulfide -- inflammation -- neuroprotection -- oxidative stress -- subarachnoid hemorrhage -- vasospasm; Neuropharmacology -- Periodicals; Central nervous system -- Diseases -- Effect of drugs on -- Periodicals; 612.8
• DOI: 10.1111/cns.13828
• Languages: English
• ISSNs: 1755-5930

Abstract

Abstract: Subarachnoid hemorrhage (SAH) is a common acute and severe disease worldwide, which imposes a heavy burden on families and society. However, the current therapeutic strategies for SAH are unsatisfactory. Hydrogen sulfide (H2 S), as the third gas signaling molecule after carbon monoxide and nitric oxide, has been widely studied recently. There is growing evidence that H2 S has a promising future in the treatment of central nervous system diseases. In this review, we focus on the effects of H2 S in experimental SAH and elucidate the underlying mechanisms. We demonstrate that H2 S has neuroprotective effects and significantly reduces secondary damage caused by SAH via antioxidant, antiinflammatory, and antiapoptosis mechanisms, and by alleviating cerebral edema and vasospasm. Based on these findings, we believe that H2 S has great potential in the treatment of SAH and warrants further study to promote its early clinical application. Abstract : Hydrogen sulfide was found to exert neuroprotective effects postexperimental subarachnoid hemorrhage (SAH) and could significantly reduce secondary damage caused by SAH via antioxidant, antiinflammatory effect, antiapoptosis, and alleviating cerebral edema and cerebral vasospasm.